MedTrace Logo

German Dementia Registry

NCT07433010 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-02-25

No results posted yet for this study

Summary

The German Dementia Registry (DEMREG) is a large-scale national prospective biomarker-based study for cognitive impairment and dementia, providing an integrated clinical research platform for research studies.

Conditions

  • Dementia Disorder

Interventions

OTHER

This is a registry.

This is an observational study; no treatments are carried out within the scope of the registry. The usual treatment/medication of patients is merely documented. Additionally, using a variety of questionnaires and tests, data is generated from participants in relation to early dementia.

Sponsors & Collaborators

  • Eisai GmbH

    collaborator INDUSTRY

  • Lilly Deutschland GmbH Germany

    collaborator UNKNOWN

  • Biogen

    collaborator INDUSTRY

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Jörg B. Schulz, Prof. Dr. · Department of Neurology, RWTH Aachen University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-16
Primary Completion
2099-12-31
Completion
2099-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07433010 on ClinicalTrials.gov